Professor Harnden succeeds Stephen Lightfoot, who served as MHRA chair from September 2020 until stepping down in 2023
Professor Anthony Harnden has officially commenced...
Illegal weight-loss medicines may contain toxins and other ingredients that could cause real harm
The Medicines and Healthcare products Regulatory Agency (MHRA) has cautioned...
Earlier this month, Aurobindo Pharma’s filgrastim biosimilar Zefylti achieved a positive opinion from EMA's CHMP
CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma, has...
The new treatment is intended for patients with moderate to severe chronic hand eczema for whom topical corticosteroids are inadequate or inappropriate.
The Medicines and...
He succeeds former MHRA chair Stephen Lightfoot who stepped down in 2023
The Medicines and Healthcare products Regulatory Agency (MHRA) has appointed Anthony Harnden, a professor of...